Published in
Elsevier, The Lancet Oncology, 9(20), p. 1306-1315, 2019
DOI: 10.1016/s1470-2045(19)30396-1
Links
Tools
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial
Journal article published in 2019 by
Michael Friedlander,
Tarek Meniawy,
Ben Markman,
Linda Mileshkin,
Paul Harnett 
,
Michael Millward,
Joanne Lundy,
Alison Freimund,
Christie Norris,
Song Mu,
John Wu,
Virginia Paton,
Bo Gao
,
Michael Millward,
Joanne Lundy,
Alison Freimund,
Christie Norris,
Song Mu,
John Wu,
Virginia Paton,
Bo Gao
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 